The intergroup rhabdomyosarcoma study: a preliminary report. 1977

H M Maurer, and T Moon, and M Donaldson, and C Fernandez, and E A Gehan, and D Hammond, and D M Hays, and W Lawrence, and W Newton, and A Ragab, and B Raney, and E H Soule, and W W Sutow, and M Tefft

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271

Related Publications

H M Maurer, and T Moon, and M Donaldson, and C Fernandez, and E A Gehan, and D Hammond, and D M Hays, and W Lawrence, and W Newton, and A Ragab, and B Raney, and E H Soule, and W W Sutow, and M Tefft
January 1982, Cancer,
H M Maurer, and T Moon, and M Donaldson, and C Fernandez, and E A Gehan, and D Hammond, and D M Hays, and W Lawrence, and W Newton, and A Ragab, and B Raney, and E H Soule, and W W Sutow, and M Tefft
January 1988, Cancer,
H M Maurer, and T Moon, and M Donaldson, and C Fernandez, and E A Gehan, and D Hammond, and D M Hays, and W Lawrence, and W Newton, and A Ragab, and B Raney, and E H Soule, and W W Sutow, and M Tefft
August 1987, Cancer,
H M Maurer, and T Moon, and M Donaldson, and C Fernandez, and E A Gehan, and D Hammond, and D M Hays, and W Lawrence, and W Newton, and A Ragab, and B Raney, and E H Soule, and W W Sutow, and M Tefft
November 1987, Archives of otolaryngology--head & neck surgery,
H M Maurer, and T Moon, and M Donaldson, and C Fernandez, and E A Gehan, and D Hammond, and D M Hays, and W Lawrence, and W Newton, and A Ragab, and B Raney, and E H Soule, and W W Sutow, and M Tefft
May 2004, The Journal of pediatrics,
H M Maurer, and T Moon, and M Donaldson, and C Fernandez, and E A Gehan, and D Hammond, and D M Hays, and W Lawrence, and W Newton, and A Ragab, and B Raney, and E H Soule, and W W Sutow, and M Tefft
May 1993, The American journal of surgical pathology,
H M Maurer, and T Moon, and M Donaldson, and C Fernandez, and E A Gehan, and D Hammond, and D M Hays, and W Lawrence, and W Newton, and A Ragab, and B Raney, and E H Soule, and W W Sutow, and M Tefft
February 2000, Journal of pediatric surgery,
H M Maurer, and T Moon, and M Donaldson, and C Fernandez, and E A Gehan, and D Hammond, and D M Hays, and W Lawrence, and W Newton, and A Ragab, and B Raney, and E H Soule, and W W Sutow, and M Tefft
August 1985, Cancer,
H M Maurer, and T Moon, and M Donaldson, and C Fernandez, and E A Gehan, and D Hammond, and D M Hays, and W Lawrence, and W Newton, and A Ragab, and B Raney, and E H Soule, and W W Sutow, and M Tefft
June 1983, Cancer,
H M Maurer, and T Moon, and M Donaldson, and C Fernandez, and E A Gehan, and D Hammond, and D M Hays, and W Lawrence, and W Newton, and A Ragab, and B Raney, and E H Soule, and W W Sutow, and M Tefft
March 1987, Ophthalmology,
Copied contents to your clipboard!